UBS Group’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-79,609
| Closed | -$1.7M | – | 9003 |
|
|
2024
Q1 | $1.7M | Sell |
79,609
-143,483
| -64% | -$3.06M | ﹤0.01% | 3110 |
|
|
2023
Q4 | $2.14M | Buy |
223,092
+129,783
| +139% | +$1.25M | ﹤0.01% | 2787 |
|
|
2023
Q3 | $243K | Sell |
93,309
-651
| -0.7% | -$1.69K | ﹤0.01% | 4135 |
|
|
2023
Q2 | $439K | Buy |
93,960
+4,174
| +5% | +$19.5K | ﹤0.01% | 3926 |
|
|
2023
Q1 | $338K | Buy |
89,786
+27,110
| +43% | +$102K | ﹤0.01% | 3971 |
|
|
2022
Q4 | $197K | Buy |
62,676
+7,772
| +14% | +$24.5K | ﹤0.01% | 4380 |
|
|
2022
Q3 | $165K | Buy |
54,904
+34,350
| +167% | +$103K | ﹤0.01% | 4225 |
|
|
2022
Q2 | $51K | Sell |
20,554
-746
| -4% | -$1.85K | ﹤0.01% | 4887 |
|
|
2022
Q1 | $165K | Buy |
21,300
+21,253
| +45,219% | +$165K | ﹤0.01% | 4520 |
|
|
2021
Q4 | $0 | Sell |
47
-4,251
| -99% | – | ﹤0.01% | 9548 |
|
|
2021
Q3 | $35K | Buy |
4,298
+473
| +12% | +$3.85K | ﹤0.01% | 5515 |
|
|
2021
Q2 | $31K | Buy |
+3,825
| New | +$31K | ﹤0.01% | 5816 |
|
|
2020
Q3 | – | Sell |
-5,484
| Closed | -$96K | – | 7478 |
|
|
2020
Q2 | $96K | Buy |
+5,484
| New | +$96K | ﹤0.01% | 4526 |
|